Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
 2016 - Forecasts to 2020 - EconoTimes)
Dublin, Sept. 05, 2016 -- Research and Markets has announced the addition of the "Global Market Report on Efungumab 2016" report to their offering.
The Global Market Report on Efungumab provides comprehensive data on Efungumab global and regional markets including Europe, Asia, North America, Latin America, etc. The report captures Efungumab market trends and pays close attention to Efungumab
The report is broken into three main parts including manufacturing methods & technology development, market landscape & trend analysis, and distribution policy.
In the manufacturing methods & technology development section, the main manufacturing methods of Efungumab are introduced.
Key Topics Covered:
Part 1: Introduction of Efungumab
Chapter 1: Brief Introduction of Efungumab
Chapter 2: Product Identification
Chapter 3: Physical Properties
Chapter 4: Quality Specifications
Part 2: Manufacture Methods and Technology Development of Efungumab
Chapter 1: Introduction of Main Manufacture Methods
Chapter 2: Introduction of Patent Manufacture Methods
Chapter 3: New Progress on the Manufacture Technology
Part 3: Application of Efungumab
Chapter 1: Application Review
Chapter 2: End Products(Downstream Products) of Efungumab
Chapter 3: New Applications of Efungumab
Part 4: Production Situation of Efungumab
Chapter 1: Current Production Situation
Chapter 2: Manufacturers in China
Chapter 3: Manufacturers Outside of China
Chapter 4: Production Trend Analysis
Part 5: Market Situation of Efungumab
Chapter 1: Market Supply Status and Trend Forecast
Chapter 2: Downstream Consumer Market Analysis
Chapter 3: Supply and Demand Analysis and Forecast
Chapter 4: Price Analysis
Chapter 5: Import & Export Situation
Part 6: Distribution Policy of Efungumab
Chapter 1: Market Size in Major Use Segments
Chapter 2: Major End Users
Chapter 3: Potential Users
Part 7: Reference
For more information about this report visit http://www.researchandmarkets.com/research/p2xz7x/global_market
Related Topics: Chemicals
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
